Ukraine registers Janssen vaccine against COVID-19

Ukraine registers Janssen vaccine against COVID-19

The Ukrainian Ministry of Health has registered the Janssen vaccine (Johnson & Johnson) for emergency medical use, according to the ministry’s press service.

“Janssen is a vector vaccine developed by Janssen, owned by Johnson & Johnson. The vaccine contains neutralized human adenovirus, which includes DNA encoding the spike protein of SARS-CoV-2 virus. It requires storage temperatures between +2 and +8 C. One shot is enough for full immunization,” reads the report.

The World Health Organization has approved a Covid-19 vaccine made by Janssen for emergency use. The vaccine has been also authorized by the United States, the United Kingdom, the European Union, Switzerland, Canada and many other countries.

As reported, Ukraine recorded 244 new COVID-19 cases on June 4.


Let’s get started read our news at facebook messenger > > > Click here for subscribe

While citing and using any materials on the Internet, links to the website not lower than the first paragraph are mandatory. In addition, citing the translated materials of foreign media outlets is possible only if there is a link to the website and to the website of a foreign media outlet. Citing and using materials in offline media, mobile apps, Smart TV are allowed only with written permission from Ukrinform. News and publications marked as "Advertisement" and "PR" and articles in the section "Releases" include promoted content, and an advertiser is responsible for the content.

© 2015-2021 Ukrinform. All rights reserved.

Website design Studio Laconica

Extended searchHide extended search
By period: